Audrey A. OʼConnor

Irradiated Cells from Autologous Tumor Cell Lines as Patient-Specific Vaccine Therapy in 125 Patients with Metastatic Cancer: Induction of Delayed-Type Hypersensitivity to Autologous Tumor is Associated with Improved Survival

Robert O. Dillman, Linda D. Beutel, Neil M. Barth et al. · Cancer Biotherapy and Radiopharmaceuticals · 2002 · 46 citations

Medicine, Immunology, Oncology +14

Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

Robert O. Dillman, Cristina DeLeon, Linda D. Beutel et al. · Critical Reviews in Oncology/Hematology · 2001 · 31 citations

Medicine, Immunology, Oncology +12

Tumor-Infiltrating Lymphocytes and Interleukin-2: Dose and Schedules of Administration in the Treatment of Metastatic Cancer

Robert O. Dillman, Patric M. Schiltz, Carol De Priest et al. · Cancer Biotherapy and Radiopharmaceuticals · 2004 · 30 citations

Life Sciences, Immunology, Oncology +17

Clinical Experience with Autologous Tumor Cell Lines for Patient-Specific Vaccine Therapy in Metastatic Melanoma

Robert O. Dillman, Shankar K. Nayak, Neil M. Barth et al. · Cancer Biotherapy and Radiopharmaceuticals · 1998 · 26 citations

Medicine, Immunology, Oncology +16

Treatment of Kidney Cancer with Autologous Tumor Cell Vaccines of Short-Term Cell Lines Derived from Renal Cell Carcinoma

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen et al. · Cancer Biotherapy and Radiopharmaceuticals · 2001 · 23 citations

Medicine, Immunology, Oncology +17